Mr. Graham Cooper was most recently the Chief Financial Officer of Receptos, Inc. from 2013 until its sale in 2015 to Celgene for $7.8 billion. Prior to joining Receptos, Inc., Mr. Cooper served as the Chief Financial Officer of both Geron Corporation and Orexigen Therapeutics. He previously held the position of Director, Health Care Investment Banking at Deutsche Bank Securities. Mr. Cooper holds a B.A. in Economics from the University of California at Berkeley and an M.B.A. from the Stanford Graduate School of Business, and has a C.P.A. Mr. Cooper is also on the Boards of Directors of Unity Biotechnology, Inc. and Kezar Life Sciences, Inc.